Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Other 1Lymphoid 1Breast 1

Conditions

Leukemia, Myeloid, Acute 121Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Lymphocytic, Chronic, B-Cell 65Hematologic Neoplasms 62Leukemia 52Myelodysplastic Syndromes 47Lymphoma 34Lymphoma, Non-Hodgkin 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28Multiple Myeloma 20Burkitt Lymphoma 20Leukemia, Myelomonocytic, Chronic 19Recurrence 18Neoplasms 17Lymphoma, Large B-Cell, Diffuse 15Leukemia, B-Cell 14Hodgkin Disease 14Myeloproliferative Disorders 13Lymphoma, Mantle-Cell 12Lymphoma, Follicular 11Leukemia, Biphenotypic, Acute 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell, Marginal Zone 10Lymphoma, B-Cell 10Anemia, Refractory, with Excess of Blasts 10Blast Crisis 8Primary Myelofibrosis 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic-Myeloproliferative Diseases 6

Interventions

obinutuzumab 1acalabrutinib 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure × Other hematologic neoplasm × 30 days × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡